Dengue & Malaria India — Warning Signs, Platelet Count, NS1 Test & Treatment Guide

Last Updated: March 2026 | Reading Time: 9 minutes | ~2,000 words

Dengue and malaria are India’s two most significant vector-borne diseases — together causing millions of illness episodes every year, with seasonal peaks that overwhelm hospital systems in the monsoon and post-monsoon period. India accounts for approximately 70% of global dengue cases in South-East Asia and reports 150,000–200,000 confirmed dengue cases annually (with true incidence estimated 5–10× higher, as most mild cases go undiagnosed). Malaria — once declared close to elimination — has resurged in tribal and forested regions. Both diseases are transmitted by mosquito bites but by entirely different mosquito species, different parasites/viruses, with different clinical courses and treatment approaches. Knowing the difference — and knowing the warning signs — can mean the difference between a managed illness and a preventable death.

Dengue vs Malaria — Key Differences

🚨 Dengue Warning Signs — When to Go to Hospital Immediately

Most dengue is a self-limiting febrile illness. But 1–5% of cases develop severe dengue — which can be fatal within hours without proper management. The critical period is Days 4–6 (the “defervescence phase” — when fever drops). Paradoxically, this is when the patient feels the fever is gone and improving — but the plasma leakage and platelet drop are at their worst. Warning signs mandating immediate hospital evaluation:

• 🔴 Abdominal pain or tenderness — indicates plasma leakage into the abdominal cavity
• 🔴 Persistent vomiting — 3+ episodes in 1 hour, preventing oral hydration
• 🔴 Clinical fluid accumulation — ascites (abdominal distension), pleural effusion (difficulty breathing lying flat)
• 🔴 Mucosal bleeding — bleeding gums, nosebleed, blood in urine (haematuria — red or tea-coloured urine), blood in stool (red or black/tarry stool)
• 🔴 Lethargy, restlessness, or confusion — altered mental status
• 🔴 Liver enlargement (>2 cm below costal margin)
• 🔴 Rapid breathing or difficulty breathing
• 🔴 Platelet count <100,000/μL with any warning sign; platelet <20,000/μL regardless of symptoms → hospitalise

Platelet Count in Dengue — Understanding the Numbers

Malaria Prevention — India-Specific Guide

Frequently Asked Questions

Can dengue be fatal — and how dangerous are low platelets?

Yes — dengue can be fatal, but the vast majority of cases (95%+) are self-limiting with appropriate supportive care. The key is understanding who is at risk for severe dengue and when. Overall mortality with good care: Less than 1% at experienced dengue treatment centres. Mortality in settings without careful fluid management and monitoring can reach 5–20% in severe dengue. Who is at highest risk for severe dengue: Second dengue infection with a different serotype — the most critical risk factor (Antibody-Dependent Enhancement: pre-existing non-neutralising antibodies from first infection actually enhance viral entry in second infection → higher viral load → more severe disease). Infants and elderly patients. People with comorbidities (diabetes, obesity, hypertension, heart disease, liver disease). Pregnancy — dengue in pregnancy carries significant maternal and neonatal risk. The platelet paradox: The most anxiety-provoking number in dengue management is the platelet count — yet platelet count alone is a poor predictor of bleeding risk in dengue. The pathophysiology is unique: in dengue, plasma leakage (capillary leak — dengue virus-induced endothelial dysfunction) → hemoconcentration and organ damage is the primary cause of death, NOT bleeding. Thrombocytopenia in dengue is caused by: virus directly infecting megakaryocytes (reduced production) + immune-mediated platelet destruction + platelet consumption at sites of vascular damage. A patient with platelets of 30,000 who has no bleeding and is well-hydrated is far safer than a patient with platelets of 60,000 who is severely dehydrated with abdominal pain and vomiting. The treatment of dengue shock syndrome is IV fluid management guided by clinical assessment — platelet transfusion is generally reserved for platelet <10,000–20,000 or active clinically significant bleeding. Unnecessary platelet transfusion (the common India practice of transfusing at 50,000 or even 80,000) wastes blood bank resources, exposes patients to transfusion risks (TRALI, infection), and does not change outcomes. Papaya leaf extract: Multiple small Indian trials show papaya leaf extract increases platelet count in dengue patients. Evidence quality is moderate (small, not blinded); some hospitals integrate it as adjunct. It is not harmful and may be used alongside standard care. It does NOT replace careful monitoring and fluid management.

Does dengue come back after recovery? What is immunity?

Immunity to dengue is serotype-specific — making repeat dengue infections not only possible but potentially more dangerous: Four serotypes: DENV-1, DENV-2, DENV-3, DENV-4. Recovery from one serotype gives lifelong immunity to that specific serotype — but only temporary cross-protection against others. After 3–6 months, cross-protection wanes. Second infection risk: A second infection with a different serotype (highly possible in urban India where multiple serotypes circulate simultaneously) carries a significantly higher risk of severe dengue through ADE (Antibody-Dependent Enhancement). In theory, a person can have dengue up to 4 times in their lifetime (one from each serotype) — each subsequent infection adding to the cumulative cocirculating serotype challenge. In India’s context: DENV-2 and DENV-3 have been dominant in recent epidemics; a person previously infected with DENV-1 (common in earlier outbreaks) is now at higher risk for severe dengue when DENV-2 circulates. This is why secondary dengue cases are typically more severe — and why the dengue vaccine is complicated. Dengue vaccine: Dengvaxia (Sanofi) — only licensed dengue vaccine; approved for use in 9–45 year olds in endemic settings BUT only in those with confirmed prior dengue infection; administering Dengvaxia to seronegative (never infected) individuals INCREASES their risk of severe dengue on first natural infection (the vaccine primes them with cross-reactive antibodies that behave like a first infection — ADE risk on second encounter). India has not yet integrated the dengue vaccine into national immunisation schedule. New generation vaccines (tetravalent live attenuated) in late-stage trials may change this.

Is malaria still a serious disease in India?

Yes — particularly P. falciparum malaria in endemic regions, which can kill within 24–48 hours of onset of severe disease. India has made remarkable progress: confirmed malaria cases dropped from 1.08 million in 2018 to approximately 175,000 in 2023 — a 84% reduction. India is on track for malaria elimination by 2027 (the National Framework for Malaria Elimination target). But elimination is not elimination from every district simultaneously: High burden districts persist: 150 high-burden districts concentrated in Odisha, Chhattisgarh, Jharkhand, Meghalaya, Mizoram, Manipur, other NE states — tribal areas with forest cover, agricultural water bodies, limited health access, and high Anopheles density. These districts account for 90%+ of India’s remaining malaria burden. Drug resistance: P. falciparum resistance to chloroquine is now nearly universal — chloroquine is no longer used for falciparum malaria India (replaced by ACT). Artemisinin partial resistance (a major global concern from Southeast Asia — Cambodia, Myanmar) has NOT yet been confirmed as indigenous to India — but imported cases exist. ACTs remain the frontline treatment. P. vivax complications: P. vivax was long considered “benign” compared to falciparum — but evidence now shows P. vivax can cause severe disease (severe anaemia, ARDS, cerebral involvement in rare cases). Vivax also causes relapsing malaria through hypnozoites in the liver — which persist after the blood stage infection clears. Primaquine 14-day course is essential for radical cure (killing liver-stage hypnozoites) — but G6PD deficiency (common in Indian populations — 5–10% prevalence) causes haemolysis with primaquine; G6PD testing before primaquine is mandatory. Malaria and pregnancy: Malaria (both falciparum and vivax) in pregnancy causes maternal anaemia, low birth weight, intrauterine growth restriction, and maternal/neonatal mortality — particularly in first trimester. Artemisinin-based therapy is CONTRAINDICATED in first trimester; quinine + clindamycin used for falciparum in T1. Chemoprophylaxis with sulphadoxine-pyrimethamine (IPTp) not routinely used in India (used in sub-Saharan Africa) but pregnant women in endemic regions should take extra vector control precautions.

Why does dengue worsen when the fever goes away?

This is one of the most counterintuitive and important pieces of clinical knowledge in dengue management — and the fatal errors frequently occur precisely at this moment: The three phases of dengue: Phase 1 — Febrile phase (Days 1–3): High fever (39–40°C), severe myalgia, headache, retro-orbital pain, anorexia. Platelet drop begins but is modest. Relatively safe phase if adequately hydrated. Phase 2 — Critical phase (Days 4–6): Fever drops — often to normal or below normal (defervescence). THIS IS THE DANGER WINDOW. The dengue virus triggers immune-mediated endothelial dysfunction → massive plasma leakage from blood vessels into surrounding tissues (interstitial spaces, pleural cavity, abdominal cavity) → intravascular volume depletion despite oedema + ascites → dengue shock syndrome if not managed. Platelet drop is most severe during this phase. Many patients and families interpret the fever breaking as recovery — discharge from hospital, reduce fluid intake, resume normal activity — precisely the wrong actions. Phase 3 — Recovery phase (Days 7–10): Plasma leakage stops; reabsorption of extravasated fluid begins; platelet count recovers rapidly (can rise from 20,000 to 1,50,000 in 48 hours) — the characteristic dengue platelet trajectory. Bradycardia (slow heart rate) common during recovery as fluid redistribution occurs. Clinical implications: The most dangerous moment in dengue management is the day the fever drops — Days 4–5. This is when hospital monitoring must be most intense, NOT when discharge should occur. The warning signs (abdominal pain, persistent vomiting, lethargy, bleeding) are most important to watch during this phase. The patient who was eating and relatively comfortable on Day 3 of fever can be in dengue shock by Day 5 — the day they feel the fever has gone. This is the message that saves lives.

How do I reduce mosquito breeding in my home?

For dengue prevention, the most critical intervention is eliminating Aedes aegypti breeding sites — because this mosquito breeds in small, clean water containers INSIDE and immediately outside homes. Government vector control teams cannot address the billions of micro-breeding sites in Indian homes — this requires individual and community action: The 10-point home checklist (search and destroy): Coolers and AC drip trays: change water every 3–5 days completely; dry and scrub the walls of the cooler (eggs are on walls, not in water); add a small amount of kerosene or insecticide tablet. Flower pots and plant saucers: remove standing water daily; place sand in saucers instead of water. Old tyres: remove them; or drill holes so they cannot accumulate water. Buckets, drums, water storage containers: keep covered with tight lids at all times; change water weekly. Discarded bottles, cups, coconut shells: remove from surroundings; ensure clean garbage collection. Roof gutters: clear leaves and ensure water flows freely. Bird baths: scrub and change water every 2–3 days. Vertical gardens and plant arrangements: avoid standing water in plant bases. Construction sites: most significant neighbourhood breeding source — covered water containers and no stagnant water in building materials mandatory. Roof water tanks: ensure they are fully covered and sealed. Community action: “Source reduction” — eliminating breeding sites — is estimated to be 30–60× more cost-effective than spraying for adult mosquitoes. Municipal authorities conduct fogging (pyrethroid insecticides) which kills adult mosquitoes temporarily — but without source reduction, Aedes populations recover within days. The combination of home source reduction + fogging in outbreak settings is most effective. Indoor protection: Mosquito nets at night (dengue also has some dusk-biting); insect repellent on skin; mosquito coils/plug-in liquid repellents for indoor spaces; mesh screens on windows.

What to Read Next

• Tuberculosis — India’s Other Major Infectious Disease Epidemic
• Iron Deficiency Anaemia — Malaria-Associated Haemolysis Superimposed on India’s Existing Anaemia Burden
• Vitamin B12 — Fever Increases B12 Utilisation; Supplement During Recovery
• Fatty Liver — Dengue Can Cause Acute Liver Injury; Monitor LFT in Hospitalised Patients
• CKD — Severe Malaria and Dengue Can Cause Acute Kidney Injury

Every monsoon, Indian hospitals fill with dengue patients — many in critical condition — who stayed home until the fever broke and then collapsed. Every year, malaria deaths occur in tribal India because the patient had no transport to a health centre. The knowledge in this article could prompt someone to act one day earlier, hydrate one litre more, ask the right question at the right moment. In dengue and malaria, one day earlier can mean the difference between recovery and the ICU.

About This Guide: Written by the StudyHub Health Editorial Team (studyhub.net.in) based on WHO Dengue Management Guidelines 2012, ISDA India guidelines, and National Vector Borne Disease Control Programme (NVBDCP) protocols. Last updated: March 2026.

Authoritative Sources: WHO Dengue Guidelines | NVBDCP India | WHO Malaria Treatment Guidelines | ICMR India

🚨 Dengue Emergency: If fever breaks AND abdominal pain, vomiting, bleeding, or restlessness occurs — go to hospital immediately. The fever breaking is NOT a sign of recovery — it is often when dengue is MOST dangerous.

⚕️ Medical Disclaimer: This article is for general information only. Never self-treat malaria. Suspected dengue or malaria requires hospitalisation if warning signs are present. Do not take aspirin or ibuprofen for dengue fever — paracetamol only.